Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    44,334 result(s) found. Displaying page 167 of 2,217.
    «« First « Previous 163  164  165  166  167  168  169  170  171  Next» Last»»
    EudraCT Number: 2007-003137-17 Sponsor Protocol Number: NAV-TXT-2007-01 Start Date*: 2008-10-17
    Sponsor Name:Grupo de Investigación en Oncología Médica del Hospital de Navarra
    Full Title: Tratamiento neoadyuvante con quimioterapia (Taxotere) y hormonoterapia en cáncer de próstata localizado de alto riesgo.
    Medical condition: Pacientes con cáncer de próstata localizado de alto riesgo.
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-003152-10 Sponsor Protocol Number: Verges Hors AOI 2007 Start Date*: 2007-10-10
    Sponsor Name:CHU DIJON
    Full Title: Influence du traitement par glitazones sur les Phospholipases A2 et sur l'effet des Lipoprotéines de haute densité (HDL) sur la réactivité artérielle, au cours du diabète de type 2
    Medical condition: Diabète de type 2
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-003156-11 Sponsor Protocol Number: 2611 Start Date*: 2007-07-06
    Sponsor Name:GOIM GRUPPO ONCOLOGICO MERIDIONALE
    Full Title: Trastuzumab, docetaxel and gemcitabine as first line treatment for HER-2 positive advanced breast cancer: a phase II of G.O.I.M.
    Medical condition: metastatised breast cancer, first line treatment
    Disease: Version SOC Term Classification Code Term Level
    10057654 PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002530-11 Sponsor Protocol Number: AFB-100 Start Date*: 2007-09-21
    Sponsor Name:Affibody AB
    Full Title: An exploratory study to assess the distribution of 111In-ABY-002 tracer uptake for SPECT imaging in subjects with metastatic HER2-positive breast cancer
    Medical condition: Female subjects having metastatic breast cancer with verified HER2 positive status (DAKO's HerceptTest) in the original primary tumor or one of the current metastases.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Suspended by CA)
    Trial results: (No results available)
    EudraCT Number: 2006-005261-19 Sponsor Protocol Number: CVAL489K2303 Start Date*: 2007-04-23
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, multicenter, double-blind, 6 week study to evaluate the dose response of valsartan on blood pressure reduction in children 6 months-5 years old with hypertension, followed by a 2 we...
    Medical condition: Hypertension
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed) DE (Completed) HU (Completed) FR (Completed) SE (Prematurely Ended) PL (Completed) IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-005269-20 Sponsor Protocol Number: 6078-PG-PSC-158 Start Date*: 2007-01-15
    Sponsor Name:LETI Pharma GmbH
    Full Title: Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of Depigoid® Grass Mix as a rush immunotherapy in patients with allergic rhinitis using an environmental ...
    Medical condition: Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitization against grass pollen.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039083 Rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005289-37 Sponsor Protocol Number: 3_1_6 Start Date*: 2007-05-16
    Sponsor Name:University Witten/Herdecke
    Full Title: Anwendung von HELIOX an einem Modell der oberen Atemwegsobstruktion
    Medical condition: A model of upper airway obstruction will be used to test the hypothesis that HELIOX 21 when additional oxygen is added (which is a common clinical situation) still can reduce the work of breathing....
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-005168-29 Sponsor Protocol Number: HXV01C Start Date*: 2008-08-13
    Sponsor Name:SANOFI PASTEUR MSD S.N.C
    Full Title: An Open-label, randomised, controlled, multi-centre study of the immunogenicity and safety of a booster dose of two different Hepatitis B vaccines to explore the anamnestic immune response in healt...
    Medical condition: anamnestic immune response in healthy 4 to 7 year-old children previously vaccinated at about 3, 5 and 11 to 13 months of age
    Disease: Version SOC Term Classification Code Term Level
    9.1 10054130 Hepatitis B immunisation LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-000972-18 Sponsor Protocol Number: SIMIDIS Start Date*: 2007-10-01
    Sponsor Name:Fundación Pethema
    Full Title: Estudio multicéntrico, no aleatorizado, abierto, para valorar la eficacia y la seguridad de la combinación de azacitidina y eritropoyetina beta en pacientes con síndromes mielodisplásicos (SMDs) de...
    Medical condition: Síndrome Mielodisplásico (SMDs) dependiente de transfusión de hematíes de riesgo bajo o intermedio -1.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000985-19 Sponsor Protocol Number: Start Date*: 2007-07-04
    Sponsor Name:University of Leuven
    Full Title: the effect of simvastatin (Zocor) on enhancement of ocular blood flow in glaucoma patients
    Medical condition: glaucoma patients
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-000986-40 Sponsor Protocol Number: EVT 101/1002 Start Date*: 2007-08-07
    Sponsor Name:Evotec NeurosciencesGmbH
    Full Title: A double blind, placebo controlled study to investigate the role of NMDA receptor NR2B subunit selective antagonism on cognitive functions and neurophysiology in healthy subjects as measured with MRI
    Medical condition: Investigation of cognitive function and neurophysiology.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-000998-30 Sponsor Protocol Number: IGG-SN-GR/DEX21P Start Date*: 2007-04-23
    Sponsor Name:ISTITUTO GIANNINA GASLINI
    Full Title: Intra-erythrocytes dexamethasone in children with cortico-dependent nephrotic syndrome a pilot study
    Medical condition: treatment of cortico-dependent nephrotic syndrome in children
    Disease: Version SOC Term Classification Code Term Level
    6.1 10018365 HLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-002200-14 Sponsor Protocol Number: AMN02 Start Date*: 2006-10-17
    Sponsor Name:ReceptoPharm Inc.
    Full Title: Randomised Placebo Controlled Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
    Medical condition: Adrenomyeloneuropathy
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002232-26 Sponsor Protocol Number: LERCA-GLOMERULAR Start Date*: 2004-11-04
    Sponsor Name:HOSPITAL 12 OCTUBRE
    Full Title: CHANGES IN GLOMERULAR HEMODINAMICS PARAMETERS IN HIPERTENSIVE PATIENTS AFTER TREATMENT WITH LERCANIDIPINE
    Medical condition: HYPERTENSION
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-004494-96 Sponsor Protocol Number: BAY 59-7939/IMP 11899 Start Date*: 2007-03-19
    Sponsor Name:Bayer HealthCare AG
    Full Title: Once-daily oral direct factor Xa inhibitor rivaroxaban in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis or pulmonary emb...
    Medical condition: Long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis or pulmonary embolism.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) ES (Completed) SE (Completed) DE (Completed) FI (Completed) FR (Completed) HU (Completed) AT (Completed) IT (Completed) DK (Completed) CZ (Completed) NL (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-000132-40 Sponsor Protocol Number: AM-111-CL-08-01 Start Date*: 2008-11-18
    Sponsor Name:Auris Medical AG
    Full Title: Efficacy of AM 111 in Patients with Acute Sensorineural Hearing Loss: A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Dose-Escalation Phase II Study
    Medical condition: Acute sensorineural hearing loss (ASNHL), which may be triggered by acoustic trauma, middle or inner ear surgery, i.e. known or evident insults to the inner ear. ASNHL may also result from a variet...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10013993 - Ear and labyrinth disorders 10040016 Sensorineural hearing loss LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2007-001912-21 Sponsor Protocol Number: caih Start Date*: 2007-06-26
    Sponsor Name:Aarhus Sygehus, Universityhospital of Aarhus
    Full Title: Bioavailability, Pharmacokinetics and Pharmacodynamics of Insulin Aspart following Subcutaneous Insulin Infusion (CSII) - Basal Rate Resolution.
    Medical condition: Type 1 diabetes mellitus Continious subcutaneous insulin infusion (CSII)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012601 Diabetes mellitus LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003761-16 Sponsor Protocol Number: 9818P Start Date*: 2005-11-24
    Sponsor Name:Department of R & D, Central Manchester and Manchester Children's Hospital NHS Trust
    Full Title: Evaluation of pneumococcal conjugate vaccine (Prevenar) in patients with myeloma and chronic lymphocytic leukaemia
    Medical condition: Pneumococcal disease is a common form of meningitis, septicaemia and pneumonia. Those individuals at highest risk include children, the elderly and persons whose immune systems are impaired. This l...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-005171-14 Sponsor Protocol Number: Start Date*: 2008-01-07
    Sponsor Name:NHS Tayside
    Full Title: A Randomised Double Blind Comparative Study of Pain During and After MAL or 5-ALA Photodynamic Therapy
    Medical condition: Bowen's disease (sqaumous cell carcinoma in-situ) and actinic keratoses
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-005557-22 Sponsor Protocol Number: NAI004/I Start Date*: 2006-02-17
    Sponsor Name:University of Dundee (Research & Innovation)
    Full Title: COMPARATIVE STUDY OF THE SYSTEMIC BIOACTIVITY OF HFA FLUTICASONE PROPIONATE VIA ANTI-STATIC SPACER DEVICES
    Medical condition: Bronchial Asthma
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 163  164  165  166  167  168  169  170  171  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 07:06:24 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA